Assignee
NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING
CN·18 granted patents·11 pending applications·23 citations·filing 2014–2022
Top patents by PatentIndex Score
29 records- 0185US9974762B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted May 22, 2018·6 cites·20 claims
- 0284US10092529B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted Oct 9, 2018·4 cites·20 claims
- 0383US10980766B2Entacapone-related compounds to treat macular degenerationNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Granted Apr 20, 2021·3 cites·4 claims
- 0481US11090307B2Treating male senescenceNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Granted Aug 17, 2021·2 cites·20 claims
- 0581US10532976B2FTO inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted Jan 14, 2020·2 cites·20 claims
- 0678US10988440B2FTO inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Granted Apr 27, 2021·1 cites·20 claims
- 0773US10004715B2Entacapone for prevention and treatment of atherosclerosisNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2014·Granted Jun 26, 2018·4 cites·9 claims
- 0867US10682329B2Entacapone for treatment of obesityNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Granted Jun 16, 2020·1 cites·15 claims
- 0964US11478438B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Granted Oct 25, 2022·0 cites·22 claims
- 1064US2023038883A1Specific host factor of hepatitis b virus infection, and use thereofNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2022·Application pending·0 cites
- 1163US2021238127A1FTO InhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2021·Application pending·0 cites
- 1261US11725000B2Apoptosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2021·Granted Aug 15, 2023·0 cites·14 claims
- 1360US11034680B2Apoptosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Granted Jun 15, 2021·0 cites·10 claims
- 1460US10555920B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Granted Feb 11, 2020·0 cites·32 claims
- 1559US10682319B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Granted Jun 16, 2020·0 cites·12 claims
- 1656US10961231B2NTCP inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Granted Mar 30, 2021·0 cites·20 claims
- 1756US2021198715A1Multiplexed immunosignal amplification using hybridization chain reaction-based methodNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Application pending·0 cites
- 1855US9845298B15-HT2B antagonistsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted Dec 19, 2017·0 cites·20 claims
- 1954US2024076412A1A bispecific antibody targeting gpc3 and cd47NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2022·Application pending·0 cites
- 2053US11229707B2Promoting immune responsesNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Granted Jan 25, 2022·0 cites·16 claims
- 2152US11666577B2MLKL inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Granted Jun 6, 2023·0 cites·20 claims
- 2252US2023041071A1Antibodies against areg and its useNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2022·Application pending·0 cites
- 2351US2018111908A15-HT2B AntagonistsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Application pending·0 cites
- 2448US2023292718A1Method for constructing model of vitiligo and the use of the modelNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Application pending·0 cites
- 2547US2021114983A1Cathepsin C inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Application pending·0 cites
- 2644US2022275055A1Drug target of idiopathic pulmonary fibrosisNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Application pending·0 cites
- 2742US2021338706A1Adenosine analog and its use in regulating the circadian clockNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Application pending·0 cites
- 2839US12594156B2Prosthesis for the lung and the use thereofNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Granted Apr 7, 2026·0 cites·16 claims
- 2938US2022273822A1Animal model of idiopathic pulmonary fibrosis, its construction method and useNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →